2022
DOI: 10.3390/cancers14102500
|View full text |Cite
|
Sign up to set email alerts
|

Fertility after Cancer: Risks and Successes

Abstract: The incidence of cancer in reproductive-aged women is 7%, but, despite the increased number of cancer cases, advances in early diagnosis and treatment have raised the survival rate. Furthermore, in the last four decades, there has been a rising trend of delaying childbearing. There has been an increasing number of couples referred to Reproductive Medicine Centers for infertility problems after one partner has been treated for cancer. In these cases, the main cause of reduced fertility derives from treatments. … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
7
0
1

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(8 citation statements)
references
References 189 publications
0
7
0
1
Order By: Relevance
“…Cancer treatments have adverse effects on ovarian function, such as delayed or arrested puberty, infertility, subfertility, and premature ovarian insufficiency (POI: menopause before age of 40) [1]. Chemotherapy damages the reproductive system by destroying the hypothalamic-pituitary axis, the uterus.…”
Section: Adolescents and Young Adultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Cancer treatments have adverse effects on ovarian function, such as delayed or arrested puberty, infertility, subfertility, and premature ovarian insufficiency (POI: menopause before age of 40) [1]. Chemotherapy damages the reproductive system by destroying the hypothalamic-pituitary axis, the uterus.…”
Section: Adolescents and Young Adultsmentioning
confidence: 99%
“…Breast cancer is the most common cancer in females worldwide, with 40% of diagnosed cases under 49 years [1]. This cancer in young women is frequently familial, with almost half of the reported cases harboring a germ line mutation in genes; tumor protein 53 (TP53), breast cancer genes 1 and 2 (BRCA1 and BRCA2) [2].…”
Section: Introductionmentioning
confidence: 99%
“…Global cancer incidence in women under 35 is estimated at around 430,000 per year, and about 73% of them currently survive [ 1 ]. However, cancer treatments can affect ovarian function and the chances of natural conception [ 2 ]. This issue is of great concern for cancer survivors, and it has therefore become mandatory to provide effective strategies for preserving fertility [ 3 6 ].…”
Section: Introductionmentioning
confidence: 99%
“…Fertility preservation options for prepubertal girls with malignant tumors include ovarian transposition, ovarian tissue cryopreservation, auto-transplantation after sexual maturity, and ovarian tissue culture in vitro [ 7 , 8 ]. However, these options are associated with the risk of re-introducing cancer cells [ 9 , 10 , 11 ].…”
Section: Introductionmentioning
confidence: 99%